DENIS MUEBAKE

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health ALBUQUERQUE, NM NPI 1124665237

General Payments — all program years on this page

$1,228.34

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 36
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $482.51 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $482.5120

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $273.324
2022 $279.876
2023 $192.646
2024 $482.5120

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078098588 Janssen Pharmaceuticals, Inc $23.29 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107703236 ABBVIE INC. $21.89 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107703238 ABBVIE INC. $24.99 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119145191 Otsuka America Pharmaceutical, Inc. $23.77 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119145193 Otsuka America Pharmaceutical, Inc. $25.68 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119145195 Otsuka America Pharmaceutical, Inc. $29.08 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120559512 Alkermes, Inc. $98.25 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143562432 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $27.11 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143562434 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $28.01 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150936082 Neurocrine Biosciences, Inc. $31.88 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150999592 Neurocrine Biosciences, Inc. $16.05 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151000138 Neurocrine Biosciences, Inc. $15.92 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151008271 Neurocrine Biosciences, Inc. $13.83 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151008761 Neurocrine Biosciences, Inc. $13.66 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151010731 Neurocrine Biosciences, Inc. $13.07 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151011009 Neurocrine Biosciences, Inc. $12.88 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151015491 Neurocrine Biosciences, Inc. $9.48 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151022320 Neurocrine Biosciences, Inc. $5.69 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151561194 Teva Pharmaceuticals USA, Inc. $26.20 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151561240 Teva Pharmaceuticals USA, Inc. $21.78 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.